Potential Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in the Perioperative Period

Anesth Analg. 2018 Jul;127(1):306-307. doi: 10.1213/ANE.0000000000003349.

Authors

Abraham H Hulst¹, Jeroen Hermanides, J Hans DeVries, Benedikt Preckel

Affiliation

¹ Department of Anesthesiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands, a.h.hulst@amc.uva.nl Department of Endocrinology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands Department of Anesthesiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

PMID: 29624529
DOI: 10.1213/ANE.0000000000003349

No abstract available

Publication types

Letter
Comment

MeSH terms

Diabetes Mellitus, Type 2*
Glucose
Humans
Hypoglycemic Agents
Perioperative Period
Sodium-Glucose Transporter 2 Inhibitors*

Substances

Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors
Glucose